ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Y.S.P. Southeast Asia Holding Bhd's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 11.31%.
As of today (2026-06-28), Y.S.P. Southeast Asia Holding Bhd's WACC % is 4.89%. Y.S.P. Southeast Asia Holding Bhd's ROC % is 6.89% (calculated using TTM income statement data).
Y.S.P. Southeast Asia Holding Bhd generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) ROC % Explanation
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Y.S.P. Southeast Asia Holding Bhd's WACC % is 4.89%. Y.S.P. Southeast Asia Holding Bhd's ROC % is 6.89% (calculated using TTM income statement data).
Y.S.P. Southeast Asia Holding Bhd generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
Be Aware
Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Y.S.P. Southeast Asia Holding Bhd ROC % Related Terms
Y.S.P. Southeast Asia Holding Bhd ROC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Operating Income data used here is four times the quarterly (Mar. 2026) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) has a ROC % of 11.31% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors.
Is Y.S.P. Southeast Asia Holding Bhd's ROC % too high?
Y.S.P. Southeast Asia Holding Bhd's current ROC % is 11.31%. The Drug Manufacturers industry median ROC % is 4.46. Y.S.P. Southeast Asia Holding Bhd's value of 11.31% is 153.6% above this industry median. Overall, Y.S.P. Southeast Asia Holding Bhd has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Y.S.P. Southeast Asia Holding Bhd's ROC % compare to ZTS and UTHR?
Y.S.P. Southeast Asia Holding Bhd's ROC % of 11.31% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.46. Y.S.P. Southeast Asia Holding Bhd's value of 11.31% is 153.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Drug Manufacturers company?
The median ROC % among Drug Manufacturers companies is 4.46, based on 982 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Y.S.P. Southeast Asia Holding Bhd's current ROC % of 11.31% is 153.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Y.S.P. Southeast Asia Holding Bhd's current ROC % is 11.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Y.S.P. Southeast Asia Holding Bhd stock overvalued right now?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) is currently considered Modestly Undervalued. The stock's GF Value™ is RM2.40, compared to a current price of RM2.04 — trading 15% below its estimated fair value. The current ROC % is 11.31% and 153.6% above the Drug Manufacturers industry median of 4.46. Y.S.P. Southeast Asia Holding Bhd's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Y.S.P. Southeast Asia Holding Bhd (XKLS:7178), the current ROC % is 11.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Overvalued in 2026?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd stock appears to be undervalued.
The current stock price of RM2.04 is trading 15% below its estimated GF Value™ of RM2.40.
GuruFocus considers Y.S.P. Southeast Asia Holding Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7178:
ROC %: 11.31%
GF Value™: RM2.40 vs. price of RM2.04 (15% below fair value)
Industry Position: 153.6% above the Drug Manufacturers median
No single metric tells the full story. See the XKLS:7178 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Y.S.P. Southeast Asia Holding Bhd Business Description
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. The company operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trading in various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is derived from Malaysia.
82GF Score
Get the complete analysis for XKLS:7178
ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7178 has been successfully added to your 
